ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
4,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5,1,Glucose tolerance test abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
6,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
6,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
8,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
9,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,2,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
11,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
12,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
14,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
16,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
17,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
18,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
21,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
22,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
23,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
24,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
24,2,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
24,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
25,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
26,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
29,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
29,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
32,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
33,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
34,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
35,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
36,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
37,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
38,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
39,1,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
39,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
39,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
40,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
41,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
41,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
43,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
44,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
44,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
45,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
47,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
48,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
49,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
49,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
50,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
52,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
53,1,Headache,Headaches NEC,Headaches,Nerv,N
53,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
55,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
56,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
58,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
59,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
59,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
60,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
61,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
62,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
62,3,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
62,4,Headache,Headaches NEC,Headaches,Nerv,N
63,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
64,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
66,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
66,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
67,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
68,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
69,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
70,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
71,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
72,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
73,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
74,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
75,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
76,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
76,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
77,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
78,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
79,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
80,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
82,1,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
83,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
83,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
85,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
86,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
87,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
88,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
89,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
90,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
90,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
92,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
93,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
95,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
96,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
99,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
100,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
101,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
101,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
102,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
103,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
104,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
105,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
106,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
107,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
108,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
109,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
109,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
110,2,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
111,1,Stress urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
112,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
112,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
113,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
113,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
113,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
113,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
114,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
